Revisiting the Therapeutic Potential of Bothrops jararaca Venom: Screening for Novel Activities Using Connectivity Mapping

Snake venoms are sources of molecules with proven and potential therapeutic applications. However, most activities assayed in venoms (or their components) are of hemorrhagic, hypotensive, edematogenic, neurotoxic or myotoxic natures. Thus, other relevant activities might remain unknown. Using functi...

Full description

Bibliographic Details
Main Authors: Carolina Alves Nicolau, Alyson Prorock, Yongde Bao, Ana Gisele da Costa Neves-Ferreira, Richard Hemmi Valente, Jay William Fox
Format: Article
Language:English
Published: MDPI AG 2018-02-01
Series:Toxins
Subjects:
Online Access:http://www.mdpi.com/2072-6651/10/2/69
_version_ 1798024306063572992
author Carolina Alves Nicolau
Alyson Prorock
Yongde Bao
Ana Gisele da Costa Neves-Ferreira
Richard Hemmi Valente
Jay William Fox
author_facet Carolina Alves Nicolau
Alyson Prorock
Yongde Bao
Ana Gisele da Costa Neves-Ferreira
Richard Hemmi Valente
Jay William Fox
author_sort Carolina Alves Nicolau
collection DOAJ
description Snake venoms are sources of molecules with proven and potential therapeutic applications. However, most activities assayed in venoms (or their components) are of hemorrhagic, hypotensive, edematogenic, neurotoxic or myotoxic natures. Thus, other relevant activities might remain unknown. Using functional genomics coupled to the connectivity map (C-map) approach, we undertook a wide range indirect search for biological activities within the venom of the South American pit viper Bothrops jararaca. For that effect, venom was incubated with human breast adenocarcinoma cell line (MCF7) followed by RNA extraction and gene expression analysis. A list of 90 differentially expressed genes was submitted to biosimilar drug discovery based on pattern recognition. Among the 100 highest-ranked positively correlated drugs, only the antihypertensive, antimicrobial (both antibiotic and antiparasitic), and antitumor classes had been previously reported for B. jararaca venom. The majority of drug classes identified were related to (1) antimicrobial activity; (2) treatment of neuropsychiatric illnesses (Parkinson’s disease, schizophrenia, depression, and epilepsy); (3) treatment of cardiovascular diseases, and (4) anti-inflammatory action. The C-map results also indicated that B. jararaca venom may have components that target G-protein-coupled receptors (muscarinic, serotonergic, histaminergic, dopaminergic, GABA, and adrenergic) and ion channels. Although validation experiments are still necessary, the C-map correlation to drugs with activities previously linked to snake venoms supports the efficacy of this strategy as a broad-spectrum approach for biological activity screening, and rekindles the snake venom-based search for new therapeutic agents.
first_indexed 2024-04-11T18:00:16Z
format Article
id doaj.art-e4dc0c3b483545528cff61b1ab695f93
institution Directory Open Access Journal
issn 2072-6651
language English
last_indexed 2024-04-11T18:00:16Z
publishDate 2018-02-01
publisher MDPI AG
record_format Article
series Toxins
spelling doaj.art-e4dc0c3b483545528cff61b1ab695f932022-12-22T04:10:32ZengMDPI AGToxins2072-66512018-02-011026910.3390/toxins10020069toxins10020069Revisiting the Therapeutic Potential of Bothrops jararaca Venom: Screening for Novel Activities Using Connectivity MappingCarolina Alves Nicolau0Alyson Prorock1Yongde Bao2Ana Gisele da Costa Neves-Ferreira3Richard Hemmi Valente4Jay William Fox5Laboratory of Toxinology, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, RJ 21040-900, BrazilDepartment of Microbiology, Immunology and Cancer Biology, University of Virginia, Charlottesville, VA 22908, USADepartment of Microbiology, Immunology and Cancer Biology, University of Virginia, Charlottesville, VA 22908, USALaboratory of Toxinology, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, RJ 21040-900, BrazilLaboratory of Toxinology, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, RJ 21040-900, BrazilDepartment of Microbiology, Immunology and Cancer Biology, University of Virginia, Charlottesville, VA 22908, USASnake venoms are sources of molecules with proven and potential therapeutic applications. However, most activities assayed in venoms (or their components) are of hemorrhagic, hypotensive, edematogenic, neurotoxic or myotoxic natures. Thus, other relevant activities might remain unknown. Using functional genomics coupled to the connectivity map (C-map) approach, we undertook a wide range indirect search for biological activities within the venom of the South American pit viper Bothrops jararaca. For that effect, venom was incubated with human breast adenocarcinoma cell line (MCF7) followed by RNA extraction and gene expression analysis. A list of 90 differentially expressed genes was submitted to biosimilar drug discovery based on pattern recognition. Among the 100 highest-ranked positively correlated drugs, only the antihypertensive, antimicrobial (both antibiotic and antiparasitic), and antitumor classes had been previously reported for B. jararaca venom. The majority of drug classes identified were related to (1) antimicrobial activity; (2) treatment of neuropsychiatric illnesses (Parkinson’s disease, schizophrenia, depression, and epilepsy); (3) treatment of cardiovascular diseases, and (4) anti-inflammatory action. The C-map results also indicated that B. jararaca venom may have components that target G-protein-coupled receptors (muscarinic, serotonergic, histaminergic, dopaminergic, GABA, and adrenergic) and ion channels. Although validation experiments are still necessary, the C-map correlation to drugs with activities previously linked to snake venoms supports the efficacy of this strategy as a broad-spectrum approach for biological activity screening, and rekindles the snake venom-based search for new therapeutic agents.http://www.mdpi.com/2072-6651/10/2/69Bothrops jararacatherapeutic potentialconnectivity mapdrug discoverybiosimilar drugs
spellingShingle Carolina Alves Nicolau
Alyson Prorock
Yongde Bao
Ana Gisele da Costa Neves-Ferreira
Richard Hemmi Valente
Jay William Fox
Revisiting the Therapeutic Potential of Bothrops jararaca Venom: Screening for Novel Activities Using Connectivity Mapping
Toxins
Bothrops jararaca
therapeutic potential
connectivity map
drug discovery
biosimilar drugs
title Revisiting the Therapeutic Potential of Bothrops jararaca Venom: Screening for Novel Activities Using Connectivity Mapping
title_full Revisiting the Therapeutic Potential of Bothrops jararaca Venom: Screening for Novel Activities Using Connectivity Mapping
title_fullStr Revisiting the Therapeutic Potential of Bothrops jararaca Venom: Screening for Novel Activities Using Connectivity Mapping
title_full_unstemmed Revisiting the Therapeutic Potential of Bothrops jararaca Venom: Screening for Novel Activities Using Connectivity Mapping
title_short Revisiting the Therapeutic Potential of Bothrops jararaca Venom: Screening for Novel Activities Using Connectivity Mapping
title_sort revisiting the therapeutic potential of bothrops jararaca venom screening for novel activities using connectivity mapping
topic Bothrops jararaca
therapeutic potential
connectivity map
drug discovery
biosimilar drugs
url http://www.mdpi.com/2072-6651/10/2/69
work_keys_str_mv AT carolinaalvesnicolau revisitingthetherapeuticpotentialofbothropsjararacavenomscreeningfornovelactivitiesusingconnectivitymapping
AT alysonprorock revisitingthetherapeuticpotentialofbothropsjararacavenomscreeningfornovelactivitiesusingconnectivitymapping
AT yongdebao revisitingthetherapeuticpotentialofbothropsjararacavenomscreeningfornovelactivitiesusingconnectivitymapping
AT anagiseledacostanevesferreira revisitingthetherapeuticpotentialofbothropsjararacavenomscreeningfornovelactivitiesusingconnectivitymapping
AT richardhemmivalente revisitingthetherapeuticpotentialofbothropsjararacavenomscreeningfornovelactivitiesusingconnectivitymapping
AT jaywilliamfox revisitingthetherapeuticpotentialofbothropsjararacavenomscreeningfornovelactivitiesusingconnectivitymapping